298380.KQ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 02:30):

ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301...

Stats
Today's Volume	507 285
Average Volume	1.05M
Market Cap	1 187.73B
EPS	KRW0 ( 2024-02-16 )
Next earnings date	( KRW0 ) 2024-05-12
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW81.03 (0.33%)

Volume Correlation

Long: 0.01 (neutral)

Short: -0.45 (neutral)

Signal:(52.619) Neutral

ABL Bio Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ABL Bio Inc. Correlation - Currency/Commodity

-0.15
( neutral )

0.06
( neutral )

-0.38
( neutral )

-0.08
( neutral )

0.64
( weak )

0.14
( neutral )

ABL Bio Inc. Financials

Annual	2023
Revenue:	KRW65.55B
Gross Profit:	KRW41.35B (63.08 %)
EPS:	KRW-55.32

Q4	2023
Revenue:	KRW8.00B
Gross Profit:	KRW952.34M (11.90 %)
EPS:	KRW-261.28

Q3	2023
Revenue:	KRW8.57B
Gross Profit:	KRW2.80B (32.72 %)
EPS:	KRW-85.85

Q2	2023
Revenue:	KRW8.59B
Gross Profit:	KRW2.92B (33.96 %)
EPS:	KRW-216.57

Financial Reports:

No articles found.

ABL Bio Inc.